Baker Bros. Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
|
|||||
2023
Q3 | $337M | Hold |
|
|||||
2023
Q2 | $330M | Hold |
|
|||||
2023
Q1 | $371M | Sell |
|
|||||
2022
Q4 | $789M | Hold |
|
|||||
2022
Q3 | $646M | Hold |
|
|||||
2022
Q2 | $632M | Hold |
|
|||||
2022
Q1 | $588M | Hold |
|
|||||
2021
Q4 | $673M | Hold |
|
|||||
2021
Q3 | $589M | Buy |
|
|||||
2021
Q2 | $633M | Hold |
|
|||||
2021
Q1 | $573M | Hold |
|
|||||
2020
Q4 | $666M | Hold |
|
|||||
2020
Q3 | $577M | Hold |
|
|||||
2020
Q2 | $936M | Hold |
|
|||||
2020
Q1 | $641M | Hold |
|
|||||
2019
Q4 | $642M | Hold |
|
|||||
2019
Q3 | $512M | Hold |
|
|||||
2019
Q2 | $650M | Hold |
|
|||||
2019
Q1 | $674M | Hold |
|
|||||
2018
Q4 | $646M | Buy |
|
|||||
2018
Q3 | $735M | Hold |
|
|||||
2018
Q2 | $714M | Hold |
|
|||||
2018
Q1 | $615M | Hold |
|
|||||
2017
Q4 | $676M | Buy |
|
|||||
2017
Q3 | $550M | Hold |
|
|||||
2017
Q2 | $536M | Buy |
|
|||||
2017
Q1 | $422M | Hold |
|
|||||
2016
Q4 | $398M | Hold |
|
|||||
2016
Q3 | $445M | Hold |
|
|||||
2016
Q2 | $374M | Hold |
|
|||||
2016
Q1 | $396M | Buy |
|
|||||
2015
Q4 | $431M | Buy |
|
|||||
2015
Q3 | $429M | Sell |
|
|||||
2015
Q2 | $560M | Sell |
|
|||||
2015
Q1 | $523M | Buy |
|
|||||
2014
Q4 | $336M | Buy |
|
|||||
2014
Q3 | $171M | Buy |
|
|||||
2014
Q2 | $119M | Buy |
|
|||||
2014
Q1 | $128M | Sell |
|
|||||
2013
Q4 | $137M | Buy |
|
|||||
2013
Q3 | $56.5M | Hold |
|
|||||
2013
Q2 | $43.7M | Buy |
|